Results 81 to 90 of about 24,653 (235)

Interpretation of Consensus of Chinese experts on pneumoconiosis treatment (2024)

open access: yes环境与职业医学
The most important revision of the Consensus of Chinese experts on pneumoconiosis treatment (2024) is to attach importance to antifibrotic treatment, and recommend tetrandrine and nintedanib for the treatment of silicosis and coal worker's pneumoconiosis,
Ling MAO
doaj   +1 more source

Assessment of Occupational Diseases among Artisans and Factory Workers in Ifo, Nigeria [PDF]

open access: yes, 2013
The ever increasing incidences of occupational diseases among workers have continually drawn the attention of researchers towards ameliorating the situation.
Dahunsi, S. O.   +2 more
core  

Pneumoconiosis [PDF]

open access: yesPostgraduate Medical Journal, 1997
J M, Joshi, N V, Kolhe, P, Sundaram
openaire   +2 more sources

Outpatient health service utilization and its influencing factors among pneumoconiosis patients combined with tuberculosis

open access: yes环境与职业医学
BackgroundTuberculosis is the most common complication of pneumoconiosis, which accelerates the progression of pneumoconiosis. Pneumoconiosis combined with tuberculosis is a major health risk.
Fengping LUO   +3 more
doaj   +1 more source

Gender Differences in Survival in Idiopathic Pulmonary Fibrosis and Following Lung Transplant [PDF]

open access: yes, 2008
Idiopathic Pulmonary Fibrosis (IPF) is a chronic and progressive form of interstitial lung disease characterized by inflammation and abnormal tissue repair ultimately leading to decreased pulmonary function and death.
Creel, Michael Eric
core  

Blockade of Wnt/β-Catenin Pathway Aggravated Silica-Induced Lung Inflammation through Tregs Regulation on Th Immune Responses

open access: yesMediators of Inflammation, 2016
CD4+ T cells play an important role in regulating silica-induced inflammation and fibrosis. Recent studies showed that Wnt/β-catenin pathway could modulate the function and the differentiation of CD4+ T cells.
Wujing Dai   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy